Kymera Therapeutics, Inc.

KYMR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$112,949$335,816$89,966$120,256
Short-Term Investments$392,733$329,629$373,184$368,488
Receivables$0$40,000$20,000$947
Inventory$0$0$0$0
Other Curr. Assets$22,616$22,882$17,801$20,577
Total Curr. Assets$528,298$728,327$500,951$510,268
Property Plant & Equip (Net)$88,075$94,617$95,906$97,864
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$478,843$303,449$312,335$362,159
Tax Assets$0$0$0$0
Other NC Assets$6,828$4,675$9,120$7,744
Total NC Assets$573,746$402,741$417,361$467,767
Other Assets$0$0$0$0
Total Assets$1,102,044$1,131,068$918,312$978,035
Liabilities
Payables$5,506$5,781$10,263$5,989
Short-Term Debt$13,743$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$23,279$40,000$11,476$13,576
Other Curr. Liab.$17,325$20,637$893$223
Total Curr. Liab.$71,575$87,540$58,989$67,767
LT Debt$0$0$0$0
Deferred Rev, NC$13,957$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$84,211$72,048$73,090$74,649
Other Liabilities$0$0$0$0
Cap. Leases$0$85,714$86,330$87,761
Total Liabilities$155,786$159,588$132,079$142,416
Equity
Pref Stock$0$0$0$0
Common Stock$7$7$7$7
Retained Earnings-$978,980-$896,805-$820,191-$754,610
AOCI$1,501$279-$58-$1,485
Other Equity$0$0$0$0
Total Equity$946,258$971,480$786,233$835,619
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,102,044$1,131,068$918,312$978,035
Net Debt-$99,206-$335,816-$89,966-$120,256